Bilal Rah

17PUBLICATIONS
50CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)BiomaterialsNaturopathyMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Mar 28, 2026
Invariant Natural Killer T Cells in Cancer Immunotherapy: Lipid-Based Modulation, Nanotechnology, and Translational Advances.

Abdulaziz A Aloliqi, Abdullah M Alnuqaydan, Mohammad Alshebremi

|Jun 27, 2025
Targeting Azole-Resistant Candida albicans: Tetrapeptide Tuftsin-Modified Liposomal Vaccine Induces Superior Immune Protection.

Masood A Khan, Arif Khan, Abdullah M Alnuqaydan

|May 27, 2025
Correction: Almutary et al. Development of 3D-Bioprinted Colitis-Mimicking Model to Assess Epithelial Barrier Function Using Albumin Nano-Encapsulated Anti-Inflammatory Drugs. Biomimetics 2023, 8, 41.

Abdulmajeed G Almutary, Abdullah M Alnuqaydan, Saleh A Almatroodi

|Nov 14, 2024
Riddelline from Tamarix articulate as a potential anti-bacterial lead compound for novel antibiotics discovery: A comprehensive computational and toxicological studies.

Abdullah M Alnuqaydan

|Sep 28, 2024
Targeting Polyprotein to Design Potential Multiepitope Vaccine against Omsk Hemorrhagic Fever Virus (OHFV) by Evaluating Allergenicity, Antigenicity, and Toxicity Using Immunoinformatic Approaches.

Abdullah M Alnuqaydan, Alaa Abdulaziz Eisa

|Nov 16, 2023
Tamarix articulata extract offers protection against toxicity induced by beauty products in Hs27 human skin fibroblasts.

Abdullah M Alnuqaydan, Faten M Ali Zainy, Abdulmajeed G Almutary

Pageof 3

Frequent Collaborators

7 joint publications

Abdulmajeed G Almutary

4 joint publications

Dinesh Kumar Chellappan

3 joint publications

Bilal Rah

2 joint publications

Keshav Raj Paudel